| Metric | შპს ნეოლაბი | შპს კრომოს ფარმა საქართველო |
|---|---|---|
| Growth | ||
| Revenue | ₾2.3m₾1.9m | ₾2.1m₾2.7m |
| Revenue growth | 21.5% | -23.2% |
| Profitability | ||
| EBITDA | -₾632k-₾787k | ₾59k₾55k |
| EBITDA margin | -26.9%-40.8% | 2.8%2.0% |
| Net profit | -₾643k-₾834k | ₾24k₾10k |
| Net margin | -27.4%-43.2% | 1.1%0.4% |
| Balance sheet | ||
| Total assets | ₾6.3m₾7.9m | ₾360k₾424k |
| Total equity | ₾6.2m₾7.7m | ₾317k₾294k |
| ROE | -10.4%-10.8% | 7.5%3.5% |